Related Experiment Video
Updated: Jul 22, 2026

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
Progress in the development of nucleic acid therapeutics
A Kalota1, V R Dondeti, A M Gewirtz
1Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, 421 Curie Blvd, Philadelphia PA, 19104, USA.
Gene silencing therapies, including antisense oligonucleotides (AS-ONs), ribozymes, and RNA interference (RNAi), offer targeted approaches for treating diseases caused by abnormal gene expression. Research focuses on improving AS-ON effectiveness and exploring clinical applications.
Area of Science:
- Molecular Biology
- Genetics
- Therapeutics
Background:
- Abnormal gene expression is a key factor in numerous diseases.
- Gene-specific downregulation presents a targeted and potentially less toxic therapeutic strategy compared to conventional treatments.
Purpose of the Study:
- To review the successes and limitations of three major gene-silencing methods: antisense oligonucleotides (AS-ONs), ribozymes/DNAzymes, and RNA interference (RNAi).
- To discuss strategies for enhancing the efficacy of antisense molecules.
- To provide an overview of clinical applications for antisense therapy.
Main Methods:
- Review of existing literature on gene-silencing strategies.
- Analysis of the mechanisms, successes, and shortcomings of AS-ONs, ribozymes/DNAzymes, and RNAi.
- Examination of approaches to improve antisense molecule effectiveness.
Main Results:
- AS-ONs, ribozymes/DNAzymes, and RNAi are established gene-silencing methods with varying degrees of success and limitations.
- Ongoing research aims to overcome challenges in delivery, stability, and off-target effects for these therapies.
- Antisense therapy has demonstrated potential in various clinical applications.
Conclusions:
- Gene-silencing technologies offer promising therapeutic avenues for diseases characterized by aberrant gene expression.
- Further development is needed to optimize the effectiveness and clinical translation of these targeted gene-downregulation strategies.
- Antisense therapy represents a significant area of development in precision medicine.
More Related Videos
09:04Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
09:20Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants
Published on: October 18, 2022
Related Concept Videos
Nucleic acids
DNA and RNA
The two main types of nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). DNA is the genetic material in all living organisms, ranging from single-celled bacteria to multicellular mammals. It is in the nucleus of eukaryotes and in the organelles, chloroplasts, and mitochondria. In prokaryotes, the...
Gene Therapy
The Central Dogma
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
Nucleic Acids
DNA and RNA
The two main types of nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). DNA is the genetic material in all living organisms, ranging from single-celled bacteria to multicellular mammals. It is in the nucleus of eukaryotes and in the organelles, chloroplasts, and mitochondria. In prokaryotes, the...
Microorganisms in Medicine and Therapeutics
Antiviral Nucleoside Inhibitors